Ocugen, Inc.

OCGN · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
359
SEC Filings

Business Summary

PART I . 1 Table of Contents OVERVIEW Ocugen is aiming to redefine the future of vision through game-changing gene therapies with the potential to address significant, unmet medical needs. Our First-in-class, breakthrough modifier gene therapy platform presents a potential paradigm shift in treating inherited retinal diseases and blindness diseases affecting millions across the globe. Our technology pipeline includes: Novel Modifier Gene Therapy Platform OCU400 - Based on the use of nuclear horm...

Next Earnings

Q2 FY2026 — expected 2026-09-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionOCGNdiscussed_in_filing Artificial Intelligence
topic_mentionOCGNdiscussed_in_filing Cybersecurity
topic_mentionOCGNdiscussed_in_filing Trusted Computing
topic_mentionOCGNdiscussed_in_filing Blockchain & Crypto
topic_mentionOCGNdiscussed_in_filing Supply Chain
topic_mentionOCGNdiscussed_in_filing Regulation
topic_mentionOCGNdiscussed_in_filing Healthcare & Bio
topic_mentionOCGNdiscussed_in_filing Platform & Ecosystem
topic_mentionOCGNdiscussed_in_filing Sovereign & Government
topic_mentionOCGNdiscussed_in_filing Artificial Intelligence
topic_mentionOCGNdiscussed_in_filing Cybersecurity
topic_mentionOCGNdiscussed_in_filing Trusted Computing
topic_mentionOCGNdiscussed_in_filing Blockchain & Crypto
topic_mentionOCGNdiscussed_in_filing Supply Chain
topic_mentionOCGNdiscussed_in_filing Regulation
topic_mentionOCGNdiscussed_in_filing Healthcare & Bio
topic_mentionOCGNdiscussed_in_filing Platform & Ecosystem
topic_mentionOCGNdiscussed_in_filing Sovereign & Government
topic_mentionOCGNdiscussed_in_filing Artificial Intelligence
topic_mentionOCGNdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-042025-12-310001628280-26-014435EDGAR102K words
2025-03-052024-12-310001628280-25-010271EDGAR—
2024-04-162023-12-310001628280-24-016378EDGAR—
2023-02-282022-12-310001628280-23-005382EDGAR—
2022-02-282021-12-310001628280-22-004085EDGAR—
2021-03-192020-12-310001628280-21-005124EDGAR—
2020-03-272019-12-310001628280-20-004221EDGAR—
2019-03-222018-12-310001564590-19-008830EDGAR—
2018-03-152017-12-310001564590-18-005711EDGAR—
2017-03-162016-12-310001193125-17-085372EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001372299-25-000013EDGAR24K words
2025-08-042025-06-300001628280-25-037310EDGAR—
2025-05-092025-03-310001628280-25-024093EDGAR—
2024-11-142024-09-300001628280-24-047846EDGAR—
2024-08-082024-06-300001628280-24-035822EDGAR—
2024-05-142024-03-310001628280-24-023038EDGAR—
2023-11-092023-09-300001628280-23-038008EDGAR—
2023-08-212023-06-300001628280-23-030128EDGAR—
2023-05-052023-03-310001628280-23-016011EDGAR—
2022-11-082022-09-300001628280-22-028775EDGAR—
2022-08-052022-06-300001628280-22-021255EDGAR—
2022-05-062022-03-310001628280-22-012850EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001628280-26-021541EDGAR4K words
2026-03-240001104659-26-033724EDGAR—
2026-03-200001104659-26-032442EDGAR—
2026-03-040001104659-26-023290EDGAR—
2026-03-040001104659-26-023288EDGAR—
2026-02-090001104659-26-011765EDGAR—
2026-01-230001104659-26-006031EDGAR—
2026-01-210001104659-26-005454EDGAR—
2026-01-150001104659-26-003900EDGAR—
2025-12-180001104659-25-122610EDGAR—

359 total filings indexed. 327 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001372299
TickerOCGN
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: a970a831aa0f92095b9a54ec14d9fe968d3d2ac2ae2eb5ab804e1cd9942c9717
parent: c3bc378c706c2a048e959bc009583b15b5f68675fff5a9ed823d4d9eea2ad9fd
content hash: 625e892ca1d56ec9b20ecff9b8b6759464d4a8baad0c4c5840b7b0933f6b6dbf
signed: 2026-04-13T04:46:40.874Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf